A two-year follow-up of oral antioxidant supplementation in primary open-angle glaucoma: an open-label, randomized, controlled trial.
第一单位:
Department of Ophthalmology, Huercal Overa Hospital, Almeria, Spain.
作者:
主题词
投药, 口服(Administration, Oral);老年人(Aged);抗高血压药(Antihypertensive Agents);抗氧化剂(Antioxidants);营养保健品(Dietary Supplements);脂肪酸类, ω3(Fatty Acids, Omega-3);女(雌)性(Female);随访研究(Follow-Up Studies);青光眼, 开角型(Glaucoma, Open-Angle);人类(Humans);眼内压(Intraocular Pressure);男(雄)性(Male);中年人(Middle Aged);神经纤维(Nerve Fibers);前瞻性研究(Prospective Studies);视网膜神经节细胞(Retinal Ganglion Cells);体层摄影术, 光学相干(Tomography, Optical Coherence);视敏度(Visual Acuity);视野测试(Visual Field Tests);视野(Visual Fields)
DOI
10.1111/aos.12629
PMID
25545196
发布时间
2019-02-21
- 浏览32

Acta ophthalmologica
546-54页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文